These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 870655)
1. Methotrexate hepatotoxicity in children with leukemia. McIntosh S; Davidson DL; O'Brien RT; Pearson HA J Pediatr; 1977 Jun; 90(6):1019-21. PubMed ID: 870655 [TBL] [Abstract][Full Text] [Related]
2. Hepatoma in a child with methotrexate-induced hepatic fibrosis. Ruymann FB; Mosijczuk AD; Sayers RJ JAMA; 1977 Dec; 238(24):2631-3. PubMed ID: 200767 [TBL] [Abstract][Full Text] [Related]
3. [Serum liver tests in patients treated with methotrexate. A retrospective analysis]. Correa G H; Paredes S N Rev Med Chil; 2007 Aug; 135(8):1002-8. PubMed ID: 17989857 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of hepatic function during maintenance therapy of acute lymphoblastic leukemia remission in children]. Mancini AF; Rosito P; Vecchi V; Vivarelli F; Faldella G; De Luca M Minerva Pediatr; 1977 Nov; 29(36):2133-42. PubMed ID: 271760 [No Abstract] [Full Text] [Related]
5. Hepatotoxicity in the treatment of acute lymphoblastic leukaemia. Topley JM; Benson J; Squier MV; Chessells JM Med Pediatr Oncol; 1979; 7(4):393-9. PubMed ID: 296787 [TBL] [Abstract][Full Text] [Related]
8. Effects of methotrexate on the liver in psoriasis. Reese LT; Grisham JW; Aach RD; Eisen AZ J Invest Dermatol; 1974 Jun; 62(6):597-602. PubMed ID: 4835782 [No Abstract] [Full Text] [Related]
9. Erythrocyte concentrations of metabolites or cumulative doses of 6-mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia. Halonen P; Mattila J; Mäkipernaa A; Ruuska T; Schmiegelow K Pediatr Blood Cancer; 2006 Jun; 46(7):762-6. PubMed ID: 16395677 [TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity of long-term methotrexate therapy for psoriasis. Tobias H; Auerbach R Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020 [No Abstract] [Full Text] [Related]
11. Liver injury associated with methotrexate therapy for psoriasis. Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150 [No Abstract] [Full Text] [Related]
12. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens. Dahl MG; Gregory MM; Scheuer PJ Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292 [TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity of methotrexate in the treatment of psoriasis. Palmer HM Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241 [No Abstract] [Full Text] [Related]
14. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Te HS; Schiano TD; Kuan SF; Hanauer SB; Conjeevaram HS; Baker AL Am J Gastroenterol; 2000 Nov; 95(11):3150-6. PubMed ID: 11095334 [TBL] [Abstract][Full Text] [Related]
18. [Iatrogenic liver fibrosis in a child as a result of treatment of lymphoblastic leukemia]. Sońta-Jakimczyk D; Mazur H; Silwa F Pediatr Pol; 1981 Feb; 56(2):175-7. PubMed ID: 6943504 [No Abstract] [Full Text] [Related]
19. [High dose methotrexate in children with acute lymphocytic leukemia]. Moe PJ Tidsskr Nor Laegeforen; 1979 Feb; 99(5):278-9,284. PubMed ID: 283580 [No Abstract] [Full Text] [Related]
20. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis. Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]